| Biotechnology Industry | Healthcare Sector | Mr. Da Lun Dong CEO | XSHE Exchange | CNE100002QB5 ISIN |
| CN Country | 1,682 Employees | 27 May 2026 Last Dividend | 4 Jul 2018 Last Split | - IPO Date |
Guiyang Xintian Pharmaceutical Co.,Ltd., established in 1995, is a prominent player in the Chinese pharmaceutical industry, focusing on the research, development, production, and sale of new Chinese patent medicines. The company is committed to addressing a wide range of diseases through its innovative products. Based in Guiyang, China, Guiyang Xintian Pharmaceutical has carved a niche for itself in the realm of traditional Chinese medicine, offering solutions that cater to various therapeutic categories.
Guiyang Xintian Pharmaceutical Co.,Ltd. offers a diverse portfolio of formulation products designed to meet various healthcare needs, including:
The company specializes in treatments across various domains including anti-tumor, gynecological, urological diseases, breast thyroid, blood supplement, heat clearing type, oral, anti-cold, and cardiovascular diseases. This comprehensive approach allows Guiyang Xintian Pharmaceutical to cater to a broad spectrum of healthcare needs, leveraging the rich heritage of Chinese patent medicines.